Buy the Unlimited Turbo PUT for Novo Nordisk at €0.64
Novo Nordisk is one of the cheapest stocks in Europe and the lowest‑priced pharma company. Over the past two months the share price has started to climb again.
The price is now close to a big gap that opened after the last earnings report, when the company cut its 2026 outlook. That gap acts like a ceiling. If the price breaks above €321.95, the downtrend could end.
Our target is a pull‑back toward support levels at 286.9 DKK and 266.4 DKK.
Why the Turbo PUT fits the picture
The Vontobel Turbo Unlimited PUT (ISIN DE000VJ00FX3) matches this technical scenario. It has no expiry date, a de‑activation barrier at 320.68 DKK and an exercise price of 333.66 DKK. The current leverage is about 6‑times.
You can buy it for €0.64. The aim is for Novo Nordisk to fall to 266.4 DKK, and the trade would be cancelled if the price reaches 321.95 DKK.
We will update the analysis when we think it’s time to exit. The targets and stop‑loss levels are for information only and can change with market conditions.
Key Numbers
| Support 1 | 286.9 |
|---|---|
| Support 2 | 266.4 |
| Resistance 1 | 321.95 |
| Resistance 2 | 357.5 |
| Target | 266.4 |
| Stop‑Loss | 321.95 |
| Short‑Term View | Negative |
| Long‑Term View | Downward |
Legal note: Future performance numbers are forecasts and do not guarantee actual results.